The upregulation of ApoC3 in cancer tissues has been reported in cancers including hepatocellular carcinoma [46] and bladder cancer [47]; besides, a significant decline of ApoC3 associated to colorectal cancer progression was also reported, which provides a significant statistical value for diagnosis [48]. This evidence concerns the gene APOC3 and colorectal cancer.